Soleus Capital Management as of Sept. 30, 2023
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 91 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr Ser Tr S&p Biotech Call Option (XBI) | 8.4 | $91M | 1.3M | 73.02 | |
United Therapeutics Corporation (UTHR) | 6.0 | $65M | 287k | 225.87 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 5.7 | $62M | 6.1M | 10.20 | |
Edap Tms S A Sponsored Adr (EDAP) | 4.1 | $44M | 6.3M | 7.02 | |
SurModics (SRDX) | 3.6 | $40M | 1.2M | 32.09 | |
Organogenesis Hldgs (ORGO) | 3.6 | $39M | 12M | 3.18 | |
GSK Sponsored Adr (GSK) | 3.2 | $34M | 943k | 36.25 | |
Humana (HUM) | 3.1 | $34M | 69k | 486.52 | |
Iradimed (IRMD) | 2.6 | $28M | 628k | 44.37 | |
Vaxcyte (PCVX) | 2.4 | $26M | 500k | 50.98 | |
Treace Med Concepts (TMCI) | 2.3 | $25M | 1.9M | 13.11 | |
Tg Therapeutics (TGTX) | 2.2 | $24M | 2.9M | 8.36 | |
Neuropace (NPCE) | 2.2 | $24M | 2.5M | 9.73 | |
Arcellx Common Stock (ACLX) | 2.1 | $23M | 644k | 35.88 | |
Tango Therapeutics (TNGX) | 2.0 | $22M | 1.9M | 11.26 | |
Insulet Corporation (PODD) | 1.9 | $20M | 128k | 159.49 | |
Evolus (EOLS) | 1.8 | $19M | 2.1M | 9.14 | |
Axogen (AXGN) | 1.7 | $19M | 3.8M | 5.00 | |
Charles River Laboratories (CRL) | 1.7 | $19M | 96k | 195.98 | |
Celcuity (CELC) | 1.7 | $19M | 2.1M | 9.14 | |
The Beauty Health Company Com Cl A (SKIN) | 1.6 | $17M | 2.8M | 6.02 | |
Axsome Therapeutics (AXSM) | 1.5 | $17M | 238k | 69.89 | |
Smith & Nephew Spdn Adr New (SNN) | 1.5 | $16M | 654k | 24.77 | |
Rigel Pharmaceuticals Com New | 1.5 | $16M | 15M | 1.08 | |
Immunovant (IMVT) | 1.4 | $15M | 400k | 38.39 | |
Krystal Biotech (KRYS) | 1.3 | $14M | 118k | 116.00 | |
Si-bone (SIBN) | 1.3 | $14M | 642k | 21.24 | |
CVS Caremark Corporation (CVS) | 1.2 | $13M | 193k | 69.82 | |
AtriCure (ATRC) | 1.2 | $13M | 306k | 43.80 | |
Essa Pharma Com New (EPIX) | 1.2 | $13M | 4.3M | 3.09 | |
Mereo Biopharma Group Spon Ads (MREO) | 1.2 | $13M | 9.7M | 1.29 | |
Bausch Health Companies (BHC) | 1.1 | $12M | 1.4M | 8.22 | |
Verastem Com New (VSTM) | 1.0 | $11M | 1.3M | 8.13 | |
Biontech Se Sponsored Ads (BNTX) | 1.0 | $11M | 98k | 108.64 | |
Inhibrx | 0.9 | $10M | 549k | 18.35 | |
Rayzebio | 0.9 | $10M | 451k | 22.20 | |
Soleno Therapeutics (SLNO) | 0.9 | $9.6M | 325k | 29.51 | |
Merus N V (MRUS) | 0.8 | $9.1M | 385k | 23.58 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.7 | $7.9M | 392k | 20.09 | |
Bioatla (BCAB) | 0.7 | $7.4M | 4.4M | 1.70 | |
Pharvaris N V (PHVS) | 0.7 | $7.2M | 344k | 20.87 | |
Compass Pathways Sponsored Ads (CMPS) | 0.7 | $7.1M | 965k | 7.40 | |
Nuvalent Inc-a (NUVL) | 0.7 | $7.1M | 154k | 45.97 | |
Inspire Med Sys (INSP) | 0.7 | $7.1M | 36k | 198.44 | |
EXACT Sciences Corporation (EXAS) | 0.6 | $7.0M | 102k | 68.22 | |
Nurix Therapeutics (NRIX) | 0.6 | $6.4M | 814k | 7.86 | |
Biolife Solutions Com New (BLFS) | 0.6 | $6.1M | 439k | 13.81 | |
Jasper Therapeutics | 0.5 | $5.8M | 8.3M | 0.70 | |
Iovance Biotherapeutics (IOVA) | 0.5 | $5.6M | 1.2M | 4.55 | |
Novocure Ord Shs (NVCR) | 0.5 | $5.6M | 344k | 16.15 | |
Insmed Com Par $.01 (INSM) | 0.5 | $5.5M | 218k | 25.25 | |
89bio (ETNB) | 0.5 | $5.3M | 346k | 15.44 | |
Urogen Pharma (URGN) | 0.5 | $5.2M | 372k | 14.01 | |
ACADIA Pharmaceuticals (ACAD) | 0.5 | $5.1M | 245k | 20.84 | |
Theratechnologies Com New (THTX) | 0.5 | $5.0M | 2.3M | 2.15 | |
C4 Therapeutics Com Stk (CCCC) | 0.5 | $5.0M | 2.7M | 1.86 | |
Castle Biosciences (CSTL) | 0.4 | $4.8M | 284k | 16.89 | |
Inspiremd (NSPR) | 0.4 | $4.5M | 1.4M | 3.27 | |
Tarsus Pharmaceuticals (TARS) | 0.4 | $4.4M | 250k | 17.77 | |
Seres Therapeutics (MCRB) | 0.4 | $4.3M | 1.8M | 2.38 | |
Mirum Pharmaceuticals (MIRM) | 0.3 | $3.3M | 103k | 31.60 | |
Applied Therapeutics (APLT) | 0.3 | $3.0M | 1.2M | 2.49 | |
Biohaven (BHVN) | 0.3 | $3.0M | 114k | 26.01 | |
Genedx Holdings Corp Com Cl A (WGS) | 0.3 | $2.8M | 781k | 3.64 | |
Kiniksa Pharmaceuticals Com Cl A | 0.3 | $2.7M | 157k | 17.37 | |
Natera (NTRA) | 0.3 | $2.7M | 61k | 44.25 | |
Design Therapeutics (DSGN) | 0.2 | $2.4M | 1.0M | 2.36 | |
Lyra Therapeutics (LYRA) | 0.2 | $2.3M | 592k | 3.91 | |
Praxis Precision Medicines I | 0.2 | $2.0M | 1.2M | 1.71 | |
Xenon Pharmaceuticals (XENE) | 0.2 | $1.8M | 52k | 34.16 | |
Syndax Pharmaceuticals (SNDX) | 0.2 | $1.7M | 120k | 14.52 | |
Aadi Bioscience (AADI) | 0.1 | $1.6M | 333k | 4.84 | |
4d Molecular Therapeutics In (FDMT) | 0.1 | $1.6M | 124k | 12.73 | |
Alkermes SHS (ALKS) | 0.1 | $1.5M | 54k | 28.01 | |
Viking Therapeutics (VKTX) | 0.1 | $1.4M | 122k | 11.07 | |
Annexon (ANNX) | 0.1 | $1.2M | 515k | 2.36 | |
Liquidia Corporation Com New (LQDA) | 0.1 | $1.1M | 175k | 6.34 | |
Avita Therapeutics (RCEL) | 0.1 | $1.1M | 75k | 14.61 | |
Karuna Therapeutics Ord | 0.1 | $1.1M | 6.4k | 169.09 | |
Avadel Pharmaceuticals Sponsored Adr | 0.1 | $1.1M | 104k | 10.30 | |
Alpine Immune Sciences | 0.1 | $1.0M | 88k | 11.45 | |
Y Mabs Therapeutics (YMAB) | 0.1 | $857k | 157k | 5.45 | |
Apogee Therapeutics (APGE) | 0.1 | $746k | 35k | 21.30 | |
Alnylam Pharmaceuticals (ALNY) | 0.1 | $691k | 3.9k | 177.10 | |
Galecto | 0.1 | $646k | 898k | 0.72 | |
Delcath Sys Com New (DCTH) | 0.1 | $587k | 145k | 4.05 | |
Silverback Therapeutics (SPRY) | 0.1 | $567k | 150k | 3.78 | |
Xeris Pharmaceuticals (XERS) | 0.1 | $566k | 304k | 1.86 | |
Xilio Therapeutics (XLO) | 0.0 | $479k | 227k | 2.11 | |
Immunic (IMUX) | 0.0 | $441k | 300k | 1.47 | |
Keros Therapeutics (KROS) | 0.0 | $405k | 13k | 31.88 |